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Abstract
Objective: Currently used valve substitutes for valve replacement have certain disadvantages that limit their long-term benefits such as
poor durability, risks of infection, thromboebolism or rejection. A tissue engineered autologous valve composed of living tissue is expected
to overcome these shortcomings with natural existing biological mechanisms for growth, repair, remodeling and development. The aim of
the study was to improve cell seeding methods for developing tissue-engineered valve tissue. Methods: Human aortic myofibroblasts were
seeded on polyglycolic acid (PGA) meshes. Cell attachment and growth of myofibroblasts on the PGA scaffolds with different seeding
intervals were compared to determine an optimal seeding interval. In addition, scanning electron microscopy study of the seeded meshes
was also performed to document tissue development. Results: There was a direct correlation between cell numbers assessed by direct
counting and MTT(3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltertra-zolium bromide) assay. Both attach rate and cell growth seeded on
meshes with long intervals (24 and 36 h) were significantly higher than those seeded with short intervals (2 and 12 h) (P , 0.01), there was
no significant difference between 24- and 36-h seeding interval. Scanning electron microscopy also documented more cell attachment with
long seeding intervals resulting in a more solid tissue like structure. Conclusion: It is feasible to use human aortic myofibroblasts to develop
a new functional tissue in vitro. Twenty-four hours is an optimal seeding interval for seeding human aortic myofibroblasts on PGA scaffolds
and MTT test is a rapid and reliable quantitative method to assess the optimal human cell seeding on polymeric meshes. Ó 1999 Elsevier
Science B.V. All rights reserved.
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1. Introduction
Valvular heart disease is a significant cause of morbidity
and mortality world wide. The state-of-the-art prosthetic
valves clinically used include xenografts, mechanical
valve and homografts. They all have certain limitations
such as poor durability, foreign body reaction, infection,
anticogulation problem or donor scarcity.
The limitations associated with various valve substitutes
have motivated the exploration of novel valve substitutes. A
series of studies have been undertaken to determine if tissue
engineering principles could be used to develop valve tissue
substitutes. Tissue engineering is a multidisciplinary
science that uses basic principles from engineering and biol-
ogy to construct tissue from their cellular components [1,2].
The advantage of this approach over whole organ/tissue
transplantation is that only the cells of interest are
implanted, and they can be potentially multiplied in vitro.
The use of human autologous cells and/or extracellular
matrix further eliminates the rejection and donor scarcity.
In cardiovascular surgery, using autologous cells to cre-
ate an autologous tissue engineered heart valve will offer
several theoretical advantages over the presently used valve
substitutes. An autologous bioprosthetic valve will be a liv-
ing structure, and therefore, it should be able to demonstrate
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the natural existing biological mechanisms for repair and
remodeling. Theoretically, a greater durability can be ex-
pected [3]. A tissue-engineered autologous heart valve will
be completely biocompatible, with minimal risk of infection
and thromboemlolic complications and without risk of
rejection. There might even be a potential for further
growth, which might be important for the pediatric patients.
The group at Boston Children’s Hospital had successfully
created tissue-engineered heart valve leaflets with animal
cells and implanted these leaflets at the pulmonary leaflet
position in lamb models. The leaflets functioned well in the
pulmonary circulation of growing lambs for up to 4 months
and no stenosis nor regurgitation could be seen [4,5].
With the obtained knowledge from animal cell study, we
therefore decided to create a tissue-engineered human heart
valve. We first focused upon the development and evalua-
tion of an adequate method. For this reason we started with
creating a living compound of human skin fibroblasts fol-
lowed by seeding of human aortic endothelial cells. The
results showed that the human skin fibroblast after 3
weeks were attached to the polymeric fibers and had spread
out and divided. The seeded endothelial cells formed a
monolayer over the human fibroblasts and no invasive
growth of endothelial cells nor a new formation of capil-
laries could be detected. The idea of creating a heart valve in
vitro was not only working with animal cells but with
human cells [6].
Seeding of human fibroblasts on biodegradable mesh is
essential for the creation of human autologous tissue-engi-
neered valve. Efforts have been made to increase cell attach-
ment to polymer scaffolds for the purpose of tissue
engineering. Improved cell attachment are achieved with
dynamic (stirred seeding or agitated seeding technique)
seeding [7,8], or precoating polymer scaffold with adhesion
factors [9].
We had used several different seeding intervals in pre-
vious studies, but which seeding interval might be optimal
for rapid cell attachment and enhanced growth remained
unclear. In our study, we focus on the seeding interval to
improve cell seeding, a rapid colorimetric assay, MTT (3-
[4,5-dimethylthiazol-2-yl]-2,5-diphenyltertra-zolium bro-
mide) test was employed to decide an optimal cell seeding
interval for seeding human aortic myofibroblast cells on to
polyglycolic acid (PGA) polymer scaffolds.
2. Materials and methods
2.1. Polymer scaffolds
Non-woven PGA polymer (a kindly gift of Dr. Vacanti,
Children’s Hospital, Harvard Medical School, Boston, MA)
was used as three-dimensional scaffolds. The fiber diameter
is 12–15 mm with a polymer density of 70 mg/ml. The
resorption capacity was 4–6 weeks by hydrolysis. In the
present study, meshes were used as square sheets of
1.0 · 1.0 · 0.3 cm in size, cold gas (ethylene oxide) ster-
ilized and were rinsed with phosphate buffered saline (PBS)
before cell seeding to remove the toxic gas residues.
2.2. Human aortic myofibroblast cell expansion
Human aortic tissue was harvested from the ascending
aorta of donor hearts for heart transplantation. After harvest-
ing, the explants were rinsed off blood with PBS and
stripped off adventitia with scissors under a laminar flow
hood (Forma Scientific, OH). Thereafter, the explants were
digested with collagenase (Collagenase Type I, Worthing-
ton Biochemical Corporation, Freehold, NJ, prepared as a
solution of 75–80 m/ml in PBS) for 30 min at room tem-
perature. After digestion, the endothelial cells were de-
tached using a rubber cell scraper and the explants were
then cut into small pieces of 2 · 2 mm. The explants were
evenly distributed over the bottom of 75 cm2 vented poly-
styrene cell culture flasks (Falcon 3111, Becton Dickinson,
Lincoln Park, NJ). After the explants were firmly attached to
the bottom of the flasks, Dulbecco’s Modified Eagles Med-
ium supplemented with 10% fetal bovine serum and 1%
streptomycin solution (Gibco BRL-Life Technologies,
Grand Island, NY) were gently added, taking care not to
dislodge the tissue pieces. The explants were placed in a
humidified incubator (Forma Scientific, OH) at 37 ° C with
5% CO2/95% air. After 5–7 days of culture, cells began to
migrate off the tissue pieces and onto the flask bottoms to
form mixed cell populations of fibroblasts and smooth mus-
cle cells (myofibroblast). After 3–4 weeks, the mixed cell
populations grew into confluent monolayers, they were seri-
ally passaged by trypsinization (trypsin/EDTA solution,
0.05/0.02%, Gibco BRL-Life Technologies, 3–5 min) and
subcultured to obtain sufficient cell numbers for polymer
scaffold seeding (passage 3–4). Medium was changed
twice a week.
2.3. Cell seeding
Human aortic myofibroblasts were trypsinized from
culture flasks and suspended to create a single cell sus-
pension. Cell number was determined by direct counting
with Neubauer counting chamber (Brand, Germany). The
cell suspension was centrifuged at 1000 rpm at 20 ° C for 5
min, the supernatant was sucked off and fresh culture med-
ium was added to create a new single cell suspension with
desired seeding cell number per 100 ml volume. Seedings
were performed in polystyrene 6-well flat-bottom culture
plate (Costar 3516, Cambridge, MA), PGA scaffolds were
placed in the center of the wells, 100 ml cell suspension of
desired seeding number was evenly distributed onto each
polymer mesh. After 2 h culture in incubator, allowing full
attachment of cells to scaffolds, medium was added 5 ml/
well for further culture. The medium had to be sucked off
before each seeding. In addition, medium was changed
daily.
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2.4. MTT assay
MTT assay determines viable cell numbers and is
based on the mitochondrial conversion of the tetrazo-
lium salt, 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenylter-
trazolium bromide (MTT). Modified MTT assay was
employed in this study to quantitatively assess the viable
cell numbers of human aortic myofibroblasts attached
and grew on PGA scaffolds. Briefly, 500 ml serum free
medium and 40 ml MTT solution (5 mg/ml in Ca2+ and
Mg2+ free PBS, Sigma, St. Louis, MO) were added to
each sample, and incubated at 37 ° C for 1 h for MTT
formazan formation. The medium and MTT were replaced
by isopropanol solution (containing 10% formic acid;
Sigma, St. Louis, MO), 400 ml per well, the samples were
incubated at 37 ° C for additional 5 min, to solve the MTT
formazan, also mildly shaken for 10 min to ensure the dis-
solution of formazan. MTT dissolved formazan solution
(100 ml) was added into 96-well ml plates (Falcon 3072,
Becton Dickinson, Lincoln Park, NJ) per well and the
absorbency values was measured using an ELISA reader
(Dynatech 5000, Dynatech, Billinghurst) at wavelength 550
nm, blanked with isopropanol solution. Two replicates
were read for each sample, the mean value of the two
was used as the final result. MTT was first performed on
a directly counted human myofibroblast cell serial
(0.5 · 105, 1.0 · 105, 1.5 · 105, 2.0 · 105, 2.5 · 105 ml),
the absorbency values were plotted against the counted cell
numbers to establish a standard calibration curve. Viable
cell numbers on meshes or culture well bottom were then
determined from the standard curve according to their MTT
absorbency.
2.5. Cell attachment and seeding intervals
Human aortic mixed cell populations (myofibroblasts,
0.5 · 106) were seeded onto PGA meshes consecutively
for six times with four different intervals: 2-, 12-, 24- and
36-h. Cultured for 2 weeks after first seeding, the cell num-
bers attached and grew on the PGA meshes (n = 4) as well
as the cell numbers unattached and grew on the culture plate
bottom (n = 6) were determined by MTT assay. The cell
numbers both grew on PGA meshes and in culture wells
were compared among different seeding interval groups to
determine an optimal seeding interval, from which a higher
viable cell number on PGA meshes but a lower cell number
in culture well were expected. Electron microscopy scan-
ning was also performed on meshes from each group to
evaluate tissue development.
2.6. Scanning electron microscopy (SEM)
Samples for SEM examination were fixed in 2% glutar-
aldehyde solution, and gradient dehydrated at critical point
followed by AuPd sputtering. Samples were observed in
JSM-255 scanning microscope (JEOL, Japan).
2.7. Statistics
Results data were expressed as mean – standard error of
the mean (SEM). Comparisons between groups were per-
formed by ANOVA test. Statistical significance was set at
P , 0.05. Linear regression analysis was utilized to evalu-
ate the correlation. Data and graphs were proceeded with
StatView 4.5 (Abacus Concepts, Berkeley, CA).
3. Results
3.1. Correlation between MTT assay and direct cell
counting
MTT was performed on directly counted human aortic
myofibroblast serial. Linear regression analysis of the
results showed that there was a linear correlation between
the cell numbers directly counted and the MTT absorbency
at 550 nm, y = - 0.056 + 2.632 · 10 - 6 x, r2 = 0.994 (Fig.
1). The presence of viable cell numbers on PGA scaffolds
in the following experiments were determined by means of
the calibration curve.
3.2. Optimal seeding interval
The same numbers of human myofibroblasts were seeded
onto the non-woven PGA meshes with four different seed-
ing intervals, namely 2-, 12-, 24-, 36-h. The myofibroblasts
attached to the PGA meshes, proliferated and produced
extracellular matrix on the meshes and grew into new tis-
sue-like architectures. After 2 weeks of culture after first
seeding, MTT assay was performed on these meshes, absor-
bency values were recorded, and the cell numbers on the
meshes were determined from the standard (Table 1). After
Fig. 1. MTT absorbency values at 550 nm were recorded and plotted
against their counterparts in directly counted human aortic myofibroblast
cell serial. There was a linear correlation between the cell numbers directly
counted and the MTT absorbency, y = - 0.056 + 2.632 · 10 - 6 x,
r
2
= 0.994.
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each seeding, the unattached myofibroblasts fished out from
the meshes to the culture wells and grew on the bottoms of
the culture wells. MTT was also performed on these cells
(Table 2). The results showed that the cell numbers unat-
tached to the PGA meshes and growing on the bottoms of
the culture wells were significantly higher in 2- and 12-h
seeding interval groups compared with those in 24- and 36-h
seeding interval groups (P , 0.01), while the cell numbers
attached and growing on the PGA meshes were significantly
lower in the 2- and 12-h seeding interval groups compared
with those in 24- and 36-h seeding interval groups
(P , 0.01). There was no significant difference of viable
cell numbers of both unattached and attached cells between
the two long seeding interval groups (24- and 36-h,
P . 0.05), while there was significant difference between
the 2- and 12-h seeding groups (P , 0.01), as shown in Fig.
2.
3.3. Scanning electron microscopy
The meshes seeded with long intervals formed more solid
tissue sheets. Electron microscope scanning examinations
revealed the attachment of the fibroblasts to the polymer
fibers and a distribution of myofibroblasts throughout the
polymeric architecture in each seeding group. Compared
with the meshes seeded with short intervals (2- and 12-h),
the cells on PGA meshes seeded with long intervals (24-,
36-h), formed a much more confluent continuous myofibro-
blasts-polymer architecture (Fig. 3). And there was no
obvious difference on meshes seeded with 24- and 36-h
intervals, which were coherent with the results of viable
cell numbers assessed by MTT assay.
The results suggested that longer seeding intervals (24- or
36-h) were optimal for cell seeding which resulted in a
higher cell attachment and growth on the PGA scaffolds
than short seeding intervals did, and there was no significant
difference of cell attachment and growth between two
longer seeding intervals (24- and 36-h).
4. Discussion
In our previous study, we successfully used human fore-
skin fibroblasts and human aortic endothelial cells to
develop a valve tissue in vitro. The cellular component of
normal heart valve tissue is composed mainly of endothelial
cells and myofibroblasts. Therefore, tissue for cell harvest-
ing and in vitro expanding can be obtained from vascular
structures that contain similar cell components [3]. Based on
this consideration, we used human aortic myofibroblast in
the present study.
In cardiovascular tissue engineering three-dimensional
polymer scaffold is used to mimic its natural counterparts,
the extracellular matrices of the body [10]. It serves as both
a physical support and as adhesive substrate for seeded cells
during in vitro culture and subsequent implantation. The
cells must first attach to three-dimensional biodegradable
polymer substrate then spread out before they start prolifer-
ating and developing into a tissue-like structure. Further-
more, the cell-polymer configuration allows for gas
exchange and diffusion of nutrients [6]. As the transplanted
cells grow and function normally, they begin to secrete their
own ECM support. Concurrently, the scaffold degrades and
is eliminated as the need for an artificial support diminishes.
Cell distribution and attachment in three dimensions are
mainly hampered by the force of gravity, therefor, rapid
attachment to the polymer surface is important [11]. Cell
adhesion to both natural and synthetic substrates is mediated
by cell attachment and spreading factors presented in the
extracellular matrix in vivo [12]. These attachment and
spreading factors are normally cellular in origin, trypsinized
cells, not surprisingly, often lack the capacity of adhere
following subcultures. When trypsinized cells are seeded,
they enter a lag period of 2–24 h, followed by a period of
exponential growth and finally enter a period of reduced or
zero growth after they become confluent [13]. Given no
extrogenous adhesion factors, the previous existing cells
on substrate might play an important role for the attachment
Table 1
MTT absorbency at 550 nm of cells on PGA meshes and viable cell numbers determined from standard curve in different seeding interval groups (n = 4)
Seeding intervals (h) 2 12 24 36
OD MTT 0.697 – 0.033 1.012 – 0.070 1.260 – 0.026 1.189 – 0.042
Cell number ( · 106) 0.285 – 0.013 0.404 – 0.026 0.498 – 0.097 0.471 – 0.016
Table 2
MTT absorbency at 550 nm of cells on culture well bottom and viable cell numbers determined from standard curve in different seeding interval groups
(n = 6)
Seeding intervals (h) 2 12 24 36
OD MTT 1.529 – 0.035 0.986 – 0.032 0.407 – 0.019 0.440 – 0.016
Cell number ( · 106) 0.600 – 0.013 0.394 – 0.012 0.176 – 0.007 0.188 – 0.006
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of subsequently seeded cells to the substrate, through pro-
viding attachment and spreading factors to enhance cell-
polymer and cell-cell attachment. In the presented study,
we find a significant higher cell attachment and growth on
PGA meshes seeded with long intervals (24- and 36-h) com-
pared with that on meshes seeded with short intervals (2-
and 12-h). This could potentially be explained by the ‘pre-
conditioning’ of the meshes by the previous seeded cells. In
the long seeding interval groups, the previous seeded cells
enter the period of exponential growth and begin to spread,
proliferate and secret, thus provide more optimal environ-
ment for cell attachment of the following seedings. There is
no difference in cell attachment and growth between the two
long seeding intervals. Compared with 36-h seeding inter-
val, 24-h seeding is more convenient to be performed, we
decided this as an optimal seeding interval for the current
purpose of study.
MTT assay was originally described by Mosmann [14]as
a useful method for the measurement of in vitro cytotoxicity
and cell proliferation. It is a semi-automated colorometric
assay which determines viable cell numbers and is based on
the conversion by mitochondrial succinate dehydrogenases
of the tetrazolium salt, 3-[4,5-dimethylthiazol-2-yl]-2,5-
diphenyltertra-zolium bromide (MTT), a water-soluble yel-
low dye, to a water-insoluble purple formazan product that
has been shown to be proportional to the numbers of living
cells presented. The formazan is then dissolved in isopro-
panol and the absorbency is recorded in photometer. The
tetrazolium ring is cleaved in active mitochondria, so the
reaction occurs only in living cells. The MTT assay has been
demonstrated as a sensitive, precise, convenient, rapid and
economical test method by many studies[15–17]. Further-
more, the advantages of this colorimetric assay is the lack of
any radioisotope. This study also proves positive correlation
among direct cell counting, MTT assay and 3H-thymidine
incorporation and DNA measurement in three-dimensional
human peritoneal fibroblast culture [18]. Our result demon-
strates a linear correlation between directly counted human
aortic myofibroblast cell number and MTT absorbency.
In conclusion, this study demonstrates the feasibility of
using human ascending aortic myofibroblasts seeded on
biodegradable polymer scaffold to develop a new functional
tissue in vitro with application of tissue engineering princi-
ples. Seeding techniques is essential for rapid cell attach-
ment, spreading and proliferation on polymer scaffolds for
in vitro culture. MTT test is a rapid and reliable quanti-
tative method to assess the optimal human cell seeding on
polymeric meshes and 24-h is an optimal seeding inter-
val for seeding human aortic myofibroblasts on PGA scaf-
folds.
These preliminary results are promising, and represent a
basic step toward construction of human autologous cardi-
ovascular valve tissue. However, the engineering of auto-
logous cardiovascular structure is still in an early stage of
development, and numerous issues remain to be investi-
gated.
Fig. 2. Comparison of viable numbers on the culture well bottom (A,
n = 6) and the cells on PGA scaffolds (B, n = 4) among the four different
seeding interval groups. Data represent the mean – SEM.
Fig. 3. Scanning electron microscopy documented the attachment of myo-
fibroblasts to the polymer fibers and a distribution of myofibroblasts
throughout the PGA meshes. Compared with the mesh seeded with 2-h
seeding interval (A), the mesh seeded with 24-h seeding interval (B)
formed a much more confluent continuous myofibroblast-polymer archi-
tecture.
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